Table 4.
Intraretinal edema | Baseline SD-OCT | 16/27 (59%) |
Improved | 10/20 (50%) | |
Stable | 9/20 (45%) | |
Worse | 1/20 (5%) | |
Final SD-OCT | 8/20 (40%) | |
Intraretinal exudates | Baseline SD-OCT | 17/27 (63%) |
Improved | 11/20 (55%) | |
Stable | 8/20 (40%) | |
Worse | 1/20 (5%) | |
Final SD-OCT | 13/20 (65%) | |
Subretinal fluid | Baseline SD-OCT | 10/27 (37%) |
Improved | 7/20 (35%) | |
Stable | 13/20 (65%) | |
Worse | 0/20 (0%) | |
Final SD-OCT | 3/20 (15%) | |
Subretinal exudates | Baseline SD-OCT | 13/27 (48%) |
Improved | 10/20 (50%) | |
Stable | 9/20 (45%) | |
Worse | 1/20 (5%) | |
Final SD-OCT | 7/20 (35%) | |
Ellipsoid zone disruption | Baseline SD-OCT | 14/27 (52%) |
Improved | 0/20 (0%) | |
Stable | 19/20 (95%) | |
Worse | 1/20 (5%) | |
Final SD-OCT | 11/20 (55%) | |
External limiting membrane disruption | Baseline SD-OCT | 11/27 (41%) |
Improved | 0/20 (0%) | |
Stable | 19/20 (95%) | |
Worse | 1/20 (5%) | |
Final SD-OCT | 9/20 (45%) |
Abbreviations: SD-OCT: spectral domain optical coherence tomography